NCT07644494

Brief Summary

This study explored how inspiratory effort affects the accuracy of the distensibility index of inferior vena cava (dIVC) in assessing fluid responsiveness (FR).This prospective observational study was conducted in an intensive care unit of a university hospital and included shock patients receiving ventilation with spontaneous breathing activity. Hemodynamic parameters were collected before and after fluid challenge by the pulse indicator continuous cardiac output. dIVC was calculated by ultrasound, and respiratory effort was assessed using airway occlusion pressure (P0.1) and end-expiratory occlusion pressure (Pocc) before fluid administration. Responders were defined by a ≥10% increase in cardiac output (CO) after 250 mL saline infused in 10 minutes. The dIVC \> 18% was considered indicative of FR. Predictive performance was evaluated using area under receiver operating characteristic curves (AUROC), stratified by P0.1 and Pocc.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 8, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 12, 2026

Completed
Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

10 months

First QC Date

June 8, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

Shock, Fluid Responsiveness, Inferior Vena Cava, Spontaneous Breathing Effort, Ultrasound

Outcome Measures

Primary Outcomes (1)

  • inspiratory effort affects the accuracy of the distensibility index of inferior vena cava in assessing fluid responsiveness

    immediate

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This prospective observational study was conducted in an intensive care unit of a university hospital and included shock patients receiving ventilation with spontaneous breathing activity

You may qualify if:

  • defined as shock who has the presence of systolic blood pressure (SBP) ≤ 90 or a \> 40 mmHg decline of SBP in patients known to be hypertensive or mean arterial pressure (MAP) ≤ 70 mmHg or requiring vasopressors to maintain SBP \> 90 mmHg or MAP \> 70 mmHg, along with signs of hypoperfusion (urinary flow \< 0.5 ml/kg/min for \> 2 h, or presence of skin mottling or blood lactate concentration ≥ 2.0 mmol/L);
  • received mechanical ventilation;
  • had the Pulse Indicator Continuous Cardiac Output (PiCCO) catheter for hemodynamic monitoring;
  • had the sign of fluid administration which include: (a) MAP \< 65 mmHg and/or SBP \< 90 mmHg; (b) the need for vasopressors; (c) urinary flow \< 0.5 ml/kg/min for \>2 h; (d) tachycardia; (e) lactic acidosis; or (f) delayed capillary refilling.

You may not qualify if:

  • were pregnant;
  • were younger than 18 years of age;
  • could not have spontaneous respiratory drive or effort measured;
  • had intra-abdominal pressure ≥ 16 cmH₂O \[15\];
  • had conditions affecting dIVC measurement, such as ECMO cannulation;
  • had factors precluding clear ultrasound imaging;
  • defined as right ventricular dysfunction who has (a) tricuspid annular plane systolic excursion \< 16 mm; (b) moderate or greater tricuspid regurgitation; (c) moderate or greater pulmonary artery hypertension\[16\];
  • expected to die within 24 hours;
  • had family members of the patient declined enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongda hospital

Nanjing, Jiangsu, China

Location

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Zhongda Hospital

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 12, 2026

Study Start

June 1, 2024

Primary Completion

March 31, 2025

Study Completion

May 31, 2025

Last Updated

June 12, 2026

Record last verified: 2026-06

Locations